Preoperative therapy is used increasingly in the treatment of patients with Stages II and III breast cancer. Randomized trials have demonstrated the equivalence of preoperative therapy to standard adjuvant therapy with respect to disease-free and overall survival, with a higher proportion of women undergoing conservative surgery instead of a mastectomy. There are multiple questions about the optimal integration of preoperative system therapy into breast cancer management. This comprehensive handbook on preoperative therapy provides guidance to the clinician for patient management, and it outlines important areas of controversy that require further research.

About Editors and Authors

TOI Masakazu is Professor of Breast Surgery in the Graduate School of Medicine, Kyoto University. He holds an MD and PhD in medicine from Hiroshima University School of Medicine, and is a specialist in breast cancer treatment. Professor Toi has acted as reviewer for many journals and is currently on the editorial board of multiple journals. He has over 300 peer-reviewed publications, and his research interests include breast cancer and cancer research.